Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dual antiretroviral therapy for HIV infection.
Soriano V, Fernandez-Montero JV, Benitez-Gutierrez L, Mendoza C, Arias A, Barreiro P, Peña JM, Labarga P. Soriano V, et al. Among authors: pena jm. Expert Opin Drug Saf. 2017 Aug;16(8):923-932. doi: 10.1080/14740338.2017.1343300. Epub 2017 Jul 11. Expert Opin Drug Saf. 2017. PMID: 28621159 Review.
Treatment of hepatitis C with new fixed dose combinations.
Soriano V, Fernandez-Montero JV, de Mendoza C, Benitez-Gutierrez L, Peña JM, Arias A, Barreiro P. Soriano V, et al. Among authors: pena jm. Expert Opin Pharmacother. 2017 Aug;18(12):1235-1242. doi: 10.1080/14656566.2017.1346609. Epub 2017 Jul 30. Expert Opin Pharmacother. 2017. PMID: 28644739 Review.
Drug interactions in HIV-infected patients treated for hepatitis C.
Soriano V, Labarga P, Fernandez-Montero JV, Mendoza C, Benítez-Gutiérrez L, Peña JM, Barreiro P. Soriano V, et al. Among authors: pena jm. Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):807-816. doi: 10.1080/17425255.2017.1351942. Epub 2017 Jul 13. Expert Opin Drug Metab Toxicol. 2017. PMID: 28689442 Review.
Drug interactions with new hepatitis C oral drugs.
Soriano V, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Peña JM. Soriano V, et al. Among authors: pena jm. Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):333-41. doi: 10.1517/17425255.2015.998997. Epub 2015 Jan 2. Expert Opin Drug Metab Toxicol. 2015. PMID: 25553890 Review.
Emerging challenges in managing hepatitis B in HIV patients.
Soriano V, Labarga P, de Mendoza C, Peña JM, Fernández-Montero JV, Benítez L, Esposito I, Barreiro P. Soriano V, et al. Among authors: pena jm. Curr HIV/AIDS Rep. 2015 Sep;12(3):344-52. doi: 10.1007/s11904-015-0275-7. Curr HIV/AIDS Rep. 2015. PMID: 26156570 Review.
Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
Esposito I, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Benítez-Gutiérrez L, Peña JM, Soriano V. Esposito I, et al. Among authors: pena jm. Expert Opin Drug Saf. 2015;14(9):1421-34. doi: 10.1517/14740338.2015.1073258. Epub 2015 Jul 28. Expert Opin Drug Saf. 2015. PMID: 26212044 Review.
New hepatitis C therapies for special patient populations.
Soriano V, Labarga P, de Mendoza C, Fernández-Montero JV, Esposito I, Benítez-Gutiérrez L, Peña JM, Barreiro P. Soriano V, et al. Among authors: pena jm. Expert Opin Pharmacother. 2016;17(2):217-29. doi: 10.1517/14656566.2016.1112790. Epub 2015 Nov 23. Expert Opin Pharmacother. 2016. PMID: 26595348
341 results